Omthera Pharma Raises $6.5 Million - Private Equity Hub
Omthera Pharmaceuticals Inc. , a Bedminster, N.J.-based developer of dyslipidemia therapies, has raised $6.5 million in Series A funding led by Sofinnova Partners . Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focusing
The time for health care reform is long overdue - Bismarck Tribune
The time for a cultural overhaul is long overdue. Our society is full blown into the idea that as individuals, groups, businesses and governments we can make any mistake, commit any foolish act and when things don’t work out the working taxpayer will
Keep informed on health care - Bismarck Tribune
Hal, I am old enough to have lived through an attempt to modernize/reform/do the right thing social security and young enough so my brain didn’t forget. Libs did a standing O when President Bush called them on it during a state of the union speech
Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis - Phramalive.com
DURHAM, N.C.–(BUSINESS WIRE)–Mar 8, 2010 - Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients
Kingsport police arrest man after he holes up in locked restroom after - Kingsport Times-News
locked restroom at the Diabetes Treatment Center, 132 W. Sevier Ave., about 3 p.m. The report states an officer had seen Bowlin walking on Sequoyah Street and attempted to talk with him about an allegation that he was involved in drug activity.
Text Size - Chicago Tribune
High doses of lead have for some time been linked to chronic kidney damage. But a recent study out of Johns Hopkins Children’s Center found that even small levels of lead exposure may be damaging to children’s kidneys. The report, published January
Omthera Pharma Raises $6.5 Million - Private Equity Hub
Omthera Pharmaceuticals Inc. , a Bedminster, N.J.-based developer of dyslipidemia therapies, has raised $6.5 million in Series A funding led by Sofinnova Partners . Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focusing
The time for health care reform is long overdue - Bismarck Tribune
The time for a cultural overhaul is long overdue. Our society is full blown into the idea that as individuals, groups, businesses and governments we can make any mistake, commit any foolish act and when things don’t work out the working taxpayer will
Keep informed on health care - Bismarck Tribune
Hal, I am old enough to have lived through an attempt to modernize/reform/do the right thing social security and young enough so my brain didn’t forget. Libs did a standing O when President Bush called them on it during a state of the union speech
Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis - Phramalive.com
DURHAM, N.C.–(BUSINESS WIRE)–Mar 8, 2010 - Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients
Kingsport police arrest man after he holes up in locked restroom after - Kingsport Times-News
locked restroom at the Diabetes Treatment Center, 132 W. Sevier Ave., about 3 p.m. The report states an officer had seen Bowlin walking on Sequoyah Street and attempted to talk with him about an allegation that he was involved in drug activity.
Text Size - Chicago Tribune
High doses of lead have for some time been linked to chronic kidney damage. But a recent study out of Johns Hopkins Children’s Center found that even small levels of lead exposure may be damaging to children’s kidneys. The report, published January